Literature DB >> 13954967

[The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease].

O HORNYKIEWICZ.   

Abstract

Entities:  

Keywords:  DOPAMINE; NOREPINEPHRINE; PARALYSIS AGITANS; SUBSTANTIA NIGRA

Mesh:

Substances:

Year:  1963        PMID: 13954967

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  44 in total

1.  [ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Arch Psychiatr Nervenkr       Date:  1964-12-02

2.  Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit.

Authors:  N Rampersaud; A Harkavyi; G Giordano; R Lever; J Whitton; Ps Whitton
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

3.  Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome.

Authors:  P Riederer; W Birkmayer; D Seemann; S Wuketich
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

Review 4.  Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.

Authors:  Stephen J Kish; Isabelle Boileau; Russell C Callaghan; Junchao Tong
Journal:  Eur J Neurosci       Date:  2016-09-05       Impact factor: 3.386

5.  Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.

Authors:  V P Barkhatova; E I Kandel'; E G Demina
Journal:  Neurosci Behav Physiol       Date:  1985 Mar-Apr

6.  Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging techniques to study metabolism.

Authors:  A Najlerahim; D M Bowen
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

Review 7.  Parkinson's disease and levodopa. A five-year follow-up and review.

Authors:  C H Markham; L J Treciokas; S G Diamond
Journal:  West J Med       Date:  1974-09

8.  [Biochemical aspects of the effect of L-dopa in patients with Parkinson's disease].

Authors:  E Gründig; F Gerstenbrand; J Oberhummer; M Simanyi; R Schedl; J Weiss
Journal:  Z Neurol       Date:  1972

9.  [Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

Authors:  W Birkmayer; M Mentasti
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1967-08-08

Review 10.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.